INTRODUCTION
Human embryonic stem cells (hESCs) (Thomson et al., 1998) and induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007) have been serving as valuable tools for basic biological research and as promising resources for regeneration therapy. Despite advances, substantial challenges remain for the clinical application of stem cells. One safety concern has been posed by the appearance of teratomas in animal models transplanted with cell samples containing a small number of undifferentiated stem cells. Methods of detecting and ablating undifferentiated stem cells are required for safer stem cell therapy.
Antibodies against stage-specific embryonic antigens 4 and 5 (SSEA-4 and SSEA-5) have been used extensively to detect human pluripotent stem cells (Henderson et al., 2002; Tang et al., 2011; Thomson et al., 1998) . SSEA-4 is a glycolipid that is expressed in early embryos and, for unknown reasons, is presented selectively on the surface of hESCs and embryonic carcinoma (EC) cells (Henderson et al., 2002) . SSEA-5, which is classified as an H-type 1 glycan, is a recently identified antigen specifically expressed in human pluripotent stem cells (Tang et al., 2011) . Other markers of human stem cells include Oct3/Oct4 and Nanog, which are transcription factors required for the maintenance of undifferentiated states of stem cells and are downregulated upon differentiation (Chambers et al., 2003; Mitsui et al., 2003; Niwa et al., 2000; Pesce and Schö ler, 2001; Rosner et al., 1990) . Although their antibodies are highly useful for detecting pluripotent cells, these unstable protein tools suffer from high cost and often require fixation and permeabilization of cells. Alkaline phosphatase is another routinely used marker of human stem cells (Shamblott et al., 1998; Thomson et al., 1995) . Although the assay for its enzymatic activity provides a simple method for detecting stem cells, this housekeeping enzyme is expressed in a number of other cell types, and its specificity to pluripotent stem cells is a major concern. A small molecule fluorescent probe specific for human pluripotent stem cells would permit their rapid detection and separation. Furthermore, small molecule probes provide reversible detection that can be tuned by varying the dose. Stable, chemically defined, and cost-effective synthetic probes would offer significant advantages as tools for basic research and for lowering the risk of tumor formation in stem cell therapy.
RESULTS

Discovery of Kyoto Probe 1
To identify a fluorescent probe that is selective for human pluripotent stem cells, we screened 326 fluorescent compounds from chemical libraries (Ahn et al., 2007; Kawazoe et al., 2011) . The image-based screening using human iPS cells (hiPSCs) isolated 21 molecules that stained hiPSCs more strongly than they stained feeder cells (mouse STO cells). We focused our subsequent efforts on a highly fluorescent rhodamine molecule (molecule 1, Kyoto probe 1 [KP-1]), which displayed the greatest selectivity ( Figures 1A-1C) . The excitation and emission spectra and fluorescent properties of KP-1 are shown in Figure S1A .
The selectivity of KP-1 for hiPSCs was confirmed by flow cytometry ( Figures 1D, S1B , and S1C). Mixtures of hiPSCs and feeder cells were treated with KP-1 ( Figure S1B ), an Alexa Fluor 647-labeled anti-SSEA-4 ( Figure S1C ), or both ( Figure 1D ). When the cells were stained simultaneously with KP-1 and the anti-SSEA-4, KP-1 stained essentially all of the SSEA-4-positive cells, but not the SSEA-4-negative cells. Thus, KP-1 is capable of differentiating between hiPSCs and feeder cells. To examine the proportion of hiPSCs that is stained by KP-1, we carried out similar experiments using feeder-free culture conditions (Figures S1D-S1G ). The results indicated that KP-1 stained 99.18% of hiPSCs, whereas an SSEA-4 antibody labeled 98.17% of hiPSCs.
An observation made during our evaluation of KP-1 further confirmed its specificity for pluripotent stem cells. When iPSCs are overgrown, central parts of the colonies tend to initiate differentiation, due to contact inhibition (Bortell et al., 1992; Green and Meuth, 1974) . Treatment with KP-1 selectively stained the undifferentiated parts of such colonies, but not the central parts ( Figures 1E and 1H ). When similar experiments were conducted with colonies of hESCs (Suemori et al., 2006) , the colonies were stained more strongly than the feeder cells ( Figures 1F and 1I ). When the colonies were partially differentiated by treatment with retinoic acid (Ben-Shushan et al., 1995) , the differentiated parts of the colonies were less densely stained (Figures 1G and 1J) . Flow cytometric analysis of hESCs and retinoid-treated differentiated cells revealed that ESCs were stained 100-fold more strongly by KP-1 than the differentiated cells (Figure 2 ). These observations suggest that KP-1 is capable of distinguishing between pluripotent stem cells and differentiated cells.
Mitochondrial Localization of KP-1
What is the basis for the selectivity of KP-1? KP-1 appears to be cell permeable, and its subcellular localization overlaps with that of MitoTracker Red (MitoRed) (Minamikawa et al., 1999) , a mitochondria-selective fluorescent marker ( Figure S2 ). MitoRed labeled mitochondria both in hiPSCs and feeder cells; however, KP-1 stained mitochondria only in iPSCs ( Figures S2A-S2E ), indicating that KP-1 localizes in the mitochondria of human pluripotent stem cells. The staining pattern of KP-1 remained the same in the presence of CCCP, an uncoupling reagent that disrupts the mitochondrial membrane potential (Heytler, 1963; Kasianowicz et al., 1984) , indicating that the staining properties of KP-1 are independent of the membrane potential ( Figures  S2F-S2I ).
To isolate mitochondrial proteins that interact with KP-1, we synthesized a chloroacetyl derivative of KP-1 ( Figure S3A ). Although this highly reactive derivative is slightly less selective than KP-1, perhaps due to its rapid formation of covalent bonds to cellular proteins (Svensson et al., 2002) , it still localized in mitochondria of hiPSCs ( Figures S3B-S3I ). We treated hiPSCs with the chloroacetyl derivative of KP-1 and used 2D SDS-PAGE to isolate mitochondrial proteins labeled with KP-1 ( Figure S3J ). Mass-sequencing analysis (Mann et al., 2001 ) of the fluorescently labeled bands revealed peptide sequences of aldehyde dehydrogenase 2 (ALDH2), a mitochondrial enzyme that has been reported to interact with a rhodamine derivative (Kim et al., 2011) . Although binding to ALDH2 might account for the mitochondrial localization of KP-1, this abundant enzyme is expressed in numerous cell types (Greenfield and Pietruszko, 1977) and is not likely to be responsible for the selectivity of KP-1 for pluripotent stem cells.
KP-1 Selectivity and ABC Transporters
Concurrent with our study of KP-1, an independent project was investigating the expression levels of 44 ATP binding cassette (ABC) transporters in hESCs and iPSCs. ABC proteins transport hydrophobic small molecules and lipids across cell membranes in an ATP-dependent manner (Moitra and Dean, 2011; Ueda, 2011; Young and Holland, 1999) and are involved in protection against xenobiotics and cholesterol homeostasis (Ueda, 2011) . The investigation with five lines of hESCs and three lines of hiPSCs showed intriguing expression patterns of four ABC proteins involved in xenobiotic efflux ( Figure 3A ). RT-PCR experiments revealed that both hESCs and iPSCs express ABCC1 (multidrug-resistance protein 1 [MRP1]) and ABCG2 (breast cancer-resistance protein [BCRP]) at detectable levels but have little, if any, expression of ABCB1 (MDR1) and ABCC2 (MRP2) transporters. Expression levels of ABCB1 and ABCG2 were markedly higher (29-and 24-fold, respectively) in differentiated cells prepared with retinoic acid, which express the differentiation marker, CDX2 (Bernardo et al., 2011; Niwa et al., 2005) , than in human pluripotent stem cells ( Figure 3B ).
We hypothesized that the selective staining of pluripotent stem cells by KP-1 is due to increased expression of ABCB1 and ABCG2 in differentiated cells, resulting in the selective export of KP-1. To investigate the role of ABCB1 and ABCG2 in the selectivity of KP-1, we established cell lines that stably express ABCB1 or ABCG2 (KB/ABCB1 and KB/ABCG2, respectively) from the KB3-1 line of human epidermoid carcinoma cells, which have undetectable expression levels of those transporters (Taguchi et al., 1997; Ueda et al., 1987) . We treated the cells with KP-1 for 2 hr, captured their images using a fluorescence microscope (Figures 4A and 4B) , and quantified the signals (Figures 4C and 4D) . Parental KB3-1 cells were strongly stained by KP-1, whereas fluorescent signals were significantly lower or undetectable in KB/ABCB1 and KB/ABCG2 cells. KP-1 staining of KB/ ABCB1 or KB/ABCG2 cells was restored by treatment with cyclosporine A or fumitremorgin C ( Figures 4A-4D ), which are known inhibitors of ABCB1 (Tamai and Safa, 1990) or ABCG2 (Allen et al., 2002) , respectively. Similar experiments were conducted with ABCC1 (MRP1), a transporter whose expression is unchanged upon cell differentiation (Chen et al., 2001; Nagata et al., 2000) . Overexpression of ABCC1 did not result in export of KP-1, whereas calcein AM, a known substrate of ABCC1 (Versantvoort et al., 1995) , was eliminated ( Figures S4A and S4B ). These results collectively suggest that KP-1 is a selective substrate for both ABCB1 and ABCG2.
We next examined the effects of transporter inhibitors on the selectivity of KP-1 for hESCs. When differentiated cells derived from ESCs were treated with cyclosporine A or fumitremorgin C, the differentiated cells were labeled by KP-1 approximately 103 more strongly than those untreated with the inhibitors (Figures 4E and 4F) . These results indicate that the selectivity of KP-1 depends on its efflux via ABCB1 and ABCG2, whose expression is repressed in human pluripotent cells and induced upon differentiation.
Selectivity Profiling of KP-1 with Human Somatic Cells
If induction levels of ABCB1 and ABCG2 expression depend on the direction and degree of differentiation from pluripotent stem cells, the usefulness of KP-1 might be limited. Previous studies have reported that either ABCG2 or ABCB1 is induced in early hematopoiesis (Tang et al., 2010; Uchida et al., 2004; Zhou et al., 2001 ); therefore, we examined KP-1 staining of hematopoietic cells derived from hESCs (Takayama et al., 2008 (Takayama et al., , 2010 ( Figure 5A ). Fluorescence-activated cell sorting (FACS) analysis showed that KP-1 distinguishes between SSEA-4-positive hESCs and human early hematopoietic cells expressing CD45, CD235, CD41a, or CD43, suggesting that KP-1 is useful for monitoring early hematopoiesis.
We next examined the ability of KP-1 to monitor other clinically important differentiation processes: cardiomyogenesis and neurogenesis. KP-1 was capable of distinguishing between hiPSCs and hiPSC-derived cardiomyocytes (Figures S5A and S5B) , as confirmed by flow cytometric analysis ( Figure 5B ). We used RT-PCR to examine the expression patterns of 44 human ABC transporters in cardiomyocytes derived from hiPSCs (Figure S4C) . Surprisingly, neither ABCG2 nor ABCB1 was induced during cardiomyogenesis. Instead, three ABC transporters, ABCA1, ABCC5, and ABCD3, were induced during differentiation ( Figure S4C ). The ability of two cell surface membrane ABC transporters, ABCA1 and ABCC5, to cause efflux of KP-1 was examined by overexpressing each transporter in HEK293 cells. However, no clear efflux of KP-1 was observed from these cells (data not shown). It is possible that cardiomyocytes have other ABC transporter-independent mechanisms for excluding KP-1.
In contrast to human cardiomyocytes, hiPSC-derived neuronal stem cells (Morizane et al., 2011) were as strongly stained by KP-1 as hiPSCs ( Figures S5C and S5D ). The inability of KP-1 to distinguish between hiPSCs and human neuronal stem cells prompted us to examine staining patterns of KP-1 in a range of human primary cells ( Figures 6A-6I ). FACS analysis showed that KP-1 stained human brain astrocytes as strongly as hiPSCs, consistent with our observation that KP-1 labels human neuronal stem cells. In contrast, KP-1 exhibited weaker staining patterns in human lung cells, human adrenal microvascular cells, human prostate epithelial cells, human hepatocytes, human bronchial epithelial cells, and human brain microvascular cells. These results are consistent with expression profiles of ABC transporters in human tissues (Langmann et al., 2003) : human tissues associated with secretion (adrenal gland), metabolic activity (liver), barrier systems (lung, bronchia), and reproductive organs (prostate) tend to display strong expression of ABC transporters. Overall, the results suggest that KP-1 is useful for monitoring a wide range of differentiation processes from human pluripotent stem cells, with the exception of neurogenesis.
We also tested staining patterns of KP-1 with several human cancer cell lines ( Figures 6J-6L ). KP-1 exhibited weaker staining in HepG2 cells (hepatocellular carcinoma) and human EC (1156QE) cells than in hiPSCs, whereas HeLa cells, a cervical cancer cell line that displays low ABC transporter expression (Ahlin et al., 2009) , were labeled by KP-1 as strongly as hiPSCs. Thus, KP-1 might find its use in classifying cancer cells. See also Figure S4 .
KP-1 Staining during Reprogramming
One potential application of KP-1 might be its use in early detection of reprogrammed cells during reprogramming. To examine this potential application, the cells brightly stained by KP-1 at an early stage of reprogramming were isolated and cultured to determine whether they did in fact correspond to fully reprogrammed iPSCs at later stages. Four reprogramming factors (Sox2, Oct3/Oct4, Klf4, and L-Myc) were virally transfected into human adrenal microvascular cells, which have broad, strong expression of ABC transporters (Langmann et al., 2003) . On day 7, the cells were treated with 2 mM KP-1 for 2 hr, then incubated overnight in fresh medium without KP-1. FACS analysis showed a significant increase in bright fluorescent cells among the transfected population (Figures S6A-S6D ). The fluorescence intensity of the cells was greater than that of mock-transfected cells and as strong as in hiPSCs. We isolated the 10% of cells most brightly stained by KP-1 and cultured them for another 3 weeks. Surprisingly, only a small portion (<0.1%) of the cells resulted in colonies of iPSCs after replating, and the reprogramming rates of the brightly stained cells were no higher than those of cells that were less strongly stained by KP-1.
During the course of the present study, the Yamanaka group independently obtained and published a similar result with an antibody against TRA-1-60, one of the most specific markers of human pluripotent cells (Tanabe et al., 2013) . By day 7, 20% of the transduced cells were positive for TRA-1-60. However, only a small portion (1%) of the reseeded TRA-1-60-positive cells resulted in the colonies of iPSCs on day 28, and many of those cells turned back to be negative for TRA-1-60 during subsequent culture. Detailed analysis showed that reprogramming of cells treated with the four reprogramming factors is initiated much more frequently than was previously anticipated and that maturation, rather than initiation, is the limiting step of the reprogramming process. Together with our results with KP-1, these observations suggest that pluripotent markers do not necessarily allow early detection of pluripotent stem cells during reprogramming. Second, how specific is the absence of ABCB1 and ABCG2 as a marker for human pluripotent cells? The expression pattern of ABC transporters might be one of many properties of human pluripotent stem cells and might not be conserved in other organisms. Previous screening of a similar chemical library with mouse ESCs identified a molecule that was not hit during the current screening (Im et al., 2010) , consistent with recent findings of properties that differ between human and mouse pluripotent stem cells (Schnerch et al., 2010) . Substrate specificities and expression patterns of ABC transporters might differ between pluripotent stem cells of humans and other species.
Finally, what are other potential applications of KP-1, in addition to detection of persistent undifferentiated stem cells in cell samples prior to transplantation? Unfortunately, our results demonstrated that KP-1 is not suited for early detection of pluripotent cells during reprogramming. However, another potential application might be monitoring of pluripotency during maintenance of hESCs or iPSCs. Visualization of hESCs or iPSCs using this stable synthetic molecule is reversible and amenable to finetuning via concentration and incubation time. No cytotoxicity of KP-1 was evident in hiPSCs under our standard staining conditions (1 or 2 mM for 2-7 hr), although cytotoxicity was detected after 48 hr of incubation at higher concentrations. The IC 50 value at 48 hr was estimated to be 5.6 mM ( Figure S6E ). Thus, prolonged incubation should be avoided when KP-1 is used at high concentrations. The staining patterns of KP-1 are time dependent, due to the involvement of ABC transporters, and 4 hr of incubation usually provided clear results.
The use of KP-1 might lead to the discovery of compounds that increase the activity of ABC transporters, either by inducing differentiation of stem cells into ABC-expressing progeny or by increasing the activity of ABC transporters in pluripotent stem cells. KP-1 might also serve as a screening tool or starting point for the discovery and design of cytotoxic drugs that are selective for human pluripotent stem cells. In theory, cytotoxic compounds with ABC transporter selectivity similar to that of KP-1 should eliminate pluripotent stem cells from a mixture of differentiated cells and undifferentiated cells.
Despite the unanswered questions, the discovery of KP-1 and elucidation of its mechanism of action constitute significant steps toward the goals of understanding the unusual characteristics of and developing a highly specific probe for human pluripotent stem cells. We plan to distribute this chemical probe to the research community for further evaluation and for use in basic studies and clinical applications.
EXPERIMENTAL PROCEDURES Chemical Library Screening
The chemical libraries of fluorescent compounds are combinations of fluorescent chemicals found or designed in multiple laboratories (Ahn et al., 2007; Kawazoe et al., 2011) . hiPSCs (clone #201B2) were plated on SNL feeder cells in 24-well plates. Five days after plating, each fluorescent compound was added at the final concentration of 4 mM. After overnight incubation, fluorescence microscopic images were captured using a Keyence Biorevo.
Characterization of KP-1 hiPSCs (clone #201B7) were plated at a density of 2 3 10 5 cells/well of a 6-well plate with mouse STO feeder cells. hiPSCs were also prepared under feederfree conditions. Six days after plating, the cells were incubated with 2 mM KP-1 for 3 hr, and fluorescence microscopic images were then captured. The cells were dissociated into single cells with Accutase (Invitrogen) and stained with a-SSEA-4-Alexa 647 for 30 min at room temperature. After washing, flow cytometric analysis was performed using a MoFlo Astrios (Beckman Coulter Genomics).
Fluorescence Microscopic Imaging of hiPSC Colonies hiPSCs (clone #201B7) were plated on SNL feeder cells in 24-or 96-well plates. Five days after plating, donut-shaped colonies of iPSCs were obtained. Differentiation of the central parts of the colonies was confirmed by immunostaining with an SSEA-1 antibody. The cells were incubated with 4 mM KP-1 for 4.5 hr at 37 C. Fluorescence microscopic images were taken using a Carl Zeiss Axioskop.
Fluorescence Microscopic Imaging and Flow Cytometric Analysis of hESCs and ESC-Derived Differentiated Cells
The hESC line, KhESC-1, was maintained as previously described (Suemori et al., 2006) . To induce differentiation, hESCs were seeded onto a Matrigelcoated plate and cultured for 4 days with 500 nM all trans-retinoic acid (Sigma-Aldrich; R2625) in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS). After staining of hESCs or the differentiated cells with 1 mM KP-1 for 2 hr, the cells were rinsed with PBS and examined using an Olympus IX71 fluorescence microscope with a DP72 camera. For flow cytometric analysis, the cells were washed twice with icecold PBS and dissociated with 0.25% trypsin-EDTA into a single cell suspension. Staining by KP-1 was quantified using a FACSCalibur flow cytometer (Becton Dickinson). For the experiments with transporter inhibitors, cyclosporin A or fumitremorgin C was added at the concentration of 10 mM, during staining with KP-1.
Expression Profile of ABC Transporters mRNA was extracted from five hESC lines (KhESC-1, KhESC-2, KhESC-3, KhESC-4, and KhESC-5) and three hiPSC lines (IMR90-1, IMR90-4, and 201B7). First-strand cDNAs were synthesized with reverse transcriptase (Applied Biosystems). Gene expression profiles were obtained by quantitative real-time RT-PCR, using TaqMan Array Gene Signature 96-well plates with 44 human ABC transporters (Applied Biosystems) and four housekeeping genes (GAPDH, 18S, HPRT1, and GUSB). Expression levels were normalized to GAPDH.
Experiments with KB3-1 Model Cells
The expression vector of myc-tagged ABCG2 in pCDH-EF1-MCS-IRES-Puro (System Biosciences) was introduced into 293T cells with psPAX2 and pMD2.G vector (Addgene). The lentivirus produced was used to infect KB3-1 cells, and a stable transformant, KB-ABCG2, was obtained by culturing the infected cells in medium containing puromycin (1 mg/ml). KB3-1, KB/ ABCB1 (Taguchi et al., 1997) , KB/ABCG2, and KB/ABCC1 (Nagata et al., 2000) cells were maintained in DMEM supplemented with 10% FBS at 37 C [Invitrogen] ) were transferred onto mitomycin-treated or irradiated C3H10T1/2 cells, and cocultured in hematopoietic cell differentiation medium with VEGF (20 ng/ml), which was replaced every 3 days. On day12 after starting differentiation, KP-1 was added to the culture medium (final concentration, 1 mM). The cells were incubated for 2 hr, then washed twice with PBS, and changed to ESC differentiation medium. Undifferentiated KhESC-3 was used as positive control, and all cells were treated with KP-1. Differentiated cells or undifferentiated cells were collected after 0, 6, and 24 hr, using treatment with 0.25% trypsin-EDTA (Invitrogen). Expression of cell surface molecules and KP-1 fluorescence were analyzed by flow cytometry (FACSAria II; Becton Dickinson).
KP-1 Staining of Cardiomyocytes
Cardiac differentiation was carried out as previously described with modifications (Minami et al., 2012; Wang et al., 2011) . In brief, hiPSCs were cultured on 3.5 cm culture dishes coated with human laminin 211 (BioLamina). To enhance generation of cardiac colonies, WNT signaling inhibitors were added for days 3-9 of cardiac differentiation. Cardiac colonies were harvested on day 15 and cultured for 7-10 days in floating culture. A majority of the prepared cells expressed the cardiac markers: cardiac troponin T, a-actinin, and NKX2.5. hiPSCs or iPSC-derived cardiomyocytes were treated with 1 mM KP-1 for 2 hr. The treated cells were rinsed with the medium and further incubated without KP-1 for 3 hr at 37 C. Fluorescent images were captured using an Olympus IX71 with a DP72 camera. For flow cytometric analysis, hiPSCs and iPSC-derived cardiomyocytes were dissociated into single cells by treatment with trypsin for 10 min. Flow cytometric analysis was performed with a FACSCalibur flow cytometer. 
